Facebook Linkedin RSS Twitter Youtube
Home 2024

Tumor-infiltrating lymphocytes

TILs Designed to Meet Solid Tumor Challenges
Bioprocessing

TILs Designed to Meet Solid Tumor Challenges

Breast Cancer Outcomes May Be Predicted More Accurately If TILs Serve as Biomarkers
Cancer

Breast Cancer Outcomes May Be Predicted More Accurately If TILs Serve as Biomarkers

Beta Blockers Revive Immune Cells Exhausted by Stress Hormone
Cancer

Beta Blockers Revive Immune Cells Exhausted by Stress Hormone

Spatial Phenotyping of the Tumor Microenvironment for Characterizing Tertiary Lymphoid Structures
Cancer

Spatial Phenotyping of the Tumor Microenvironment for Characterizing Tertiary Lymphoid Structures

Single-Cell Functional Proteomics
OMICs

Single-Cell Functional Proteomics

Astellas Acquires Collaboration Partner Potenza, Adding Cancer Immunotherapy Programs
Cancer

Astellas Acquires Collaboration Partner Potenza, Adding Cancer Immunotherapy Programs

Precision Biomarkers and Medicines Go Global
Insights

Precision Biomarkers and Medicines Go Global

Aim Immuno-Oncology at “Trunk” Antigens, Not “Branch” Antigens
Drug Discovery

Aim Immuno-Oncology at “Trunk” Antigens, Not “Branch” Antigens

“Know Your Enemy” Takes Cell Therapy to Next Level
Insights

“Know Your Enemy” Takes Cell Therapy to Next Level

Immune Cells from Cancer Patient Drafted into Treatment, Force Tumor Retreat
Cancer

Immune Cells from Cancer Patient Drafted into Treatment, Force Tumor Retreat

12Page 1 of 2
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.